1. Rallying Oncologists to Social Media
for Clinical Trials
Michael J. Fisch, MD, MPH
@fischmd
June 7, 2018
2. Disclosures
AIM Specialty HealthÂŽ
⢠Subsidiary of Anthem, Inc.
⢠Employment (full-time)
MD Anderson Cancer Center
⢠Clinical specialist (part-time)
⢠Previously on faculty for 15 years
NCI Network group affiliations
⢠SWOG (current)
⢠ECOG-ACRIN (previous)
3. Key Messages
⢠Twitter is currently the major social platform for
MDs to engage the public and each other
⢠Many different categories of content on Twitter
can influence clinical trials
⢠Rallying other MDs to Twitter to help with
education and ultimately enrollment on clinical
trials has not been easy or highly successful
so farâŚ
4.
5. Five Reasons for Oncologists to Use Twitter
1. To find information
2. To amplify good information
3. To be found and seen
4. To actively create tweets to share
information
5. To actively engage with others
8. Research Concerns
⢠Descriptions of ongoing trials could be considered
inducement to research
⢠No OHRP or FDA guidance exists regarding social media
9. SWOG CCOP Research Base
Grant Renewal 2012
Specific aim: To use blogs and microblogs
(via Twitter) to promote clinical trial accrual
in SWOG and also to promote the science of
oncology and the value of research-driven
patient care among our community oncology
sites, academic cancer center faculty and
fellows, other academic centers, and the lay
public.
10. Michael J. Fisch, MD MPH
The University of Texas MD Anderson
Cancer Center
SWOG Plenary: May 4, 2013
11. Bottom Line
ďĄ The more SWOG members who tweet
ďˇ the more we will learn from each other
ďˇunderstand the perspectives of patients and
caregivers
ďˇinfluence cancer care and science for the better
through our clinical trials
12. Next Steps
ďĄ Sign up on twitter
ďĄ Send a tweet to SWOG
@SWOG, letâs engage! #swogonc
ďĄ Social Media WG
@fischmd count me in for @SWOG SM
Let Er Rip!!
@SWOGChair
13.
14. Why arenât you doing more SM?
ďĄ You are crazy busy
ďĄ Seems like a narcissistic indulgence
ďĄ Youâve seen some bad things can happen
ďĄ Havenât seen anything that great on SM
ďĄ Nobody showed you how to get started
ďĄ Had a bad experience with it and quit
15.
16. Ideas Moving Forward
⢠More local institutional
encouragement and support
⢠Critical mass of local
mentors
⢠Crawl/Walk/Run
ďź Teach oncologists to
extract information
from Twitter without
having to agree to
tweet (or even sign up)
17. Key Messages
⢠Twitter is currently the major social
platform for MDs to engage the public and
each other
⢠Many different categories of content on
Twitter can influence clinical trials
⢠Rallying other MDs to Twitter to help with
education and ultimately enrollment on
clinical trials has not been easy or highly
successful so farâŚbut that may change
Editor's Notes
My narrative with clinical trials and social media:
Fellowship trainingâacculturated to clinical trials and NCI networks
Early careerâactive in NCI network research (ECOG)
Mid-career
Became PI of the MDACC Community Clinical Oncology Research Base
Tried to rally MDACC and ASCO to promote engagement through a cancer radio concept
Noticed the power of twitter after the Arab Spring, tried to rally our clinical trial partners (including @mtmdphd) to action
Recent years
Trying to rally MDACC colleagues and SWOG colleagues
SWOG plenary talk on social media
ASCO sessions on social media
Co-authored papers on social media in oncology
Member of SWOG Digital Enagement Committee
Fisch slide from ASCO 2011 meeting in an education session under the professional development track called âManaging Electronic Educationâ
Good afternoon. Iâve been asked to talk about social media plans for the group.
Hereâs what Iâm asking you to doâŚ.
My narrative with clinical trials and social media:
Fellowship trainingâacculturated to clinical trials and NCI networks
Early careerâactive in NCI network research (ECOG)
Mid-career
Became PI of the MDACC Community Clinical Oncology Research Base
Tried to rally MDACC and ASCO to promote engagement through a cancer radio concept
Noticed the power of twitter after the Arab Spring, tried to rally our clinical trial partners (including @mtmdphd) to action
Recent years
Trying to rally MDACC colleagues and SWOG colleagues
SWOG plenary talk on social media
ASCO sessions on social media
Co-authored papers on social media in oncology
Member of SWOG Digital Enagement Committee